Resources

A dermal patch containing 5% lidocaine (Lidoderm) proved as effective as pregabalin (Lyrica) in relieving neuropathic pain in diabetic patients with dramatically fewer side effects.

An investigational drug targeting an insulin-independent pathway in Type 2 diabetes produced early and substantial reductions in blood glucose and body weight in a phase III study.

European organizations are calling for improved care and screening for CVD and diabetes in those with mental illnesses.

Seventy-six percent higher dose of insulin detemir needed to achieve similar, well tolerated glycemic control versus Lantus®.

Researchers are reporting that treatment of even the mildest forms of gestational diabetes halves the risk of delivering newborns with excess body fat and shoulder dystocia at birth. Treatment also results in fewer cesarean deliveries and a reduction in risk for pre-eclampsia and hypertensive disorders.

Metformin was found to reduce risk in pancreatic and colon cancers in patients with Type 2 diabetes in an epidemiologic study.

Long-term study in adults with Type 2 diabetes presented at the 45th annual meeting of the European Association for the Study of Diabetes.

Patients taking insulin-based drugs for diabetes appear prone to increased rates of cancer diagnosis, but there appears to be no special risk for insulin glargine (Lantus) compared with other insulins, researchers said.

XOMA, a leader in the discovery and development of therapeutic antibodies, announced new data demonstrating the unique regulatory mechanism of action of XOMA 052, a potent antibody drug candidate that inhibits the inflammatory cytokine interleukin-1 beta (IL-1 beta). XOMA 052 is currently under study for the treatment of patients with …

People who are at high risk of experiencing a heart attack or stroke can reduce their risk by up to 80 percent if they take a combination of three inexpensive drugs, according to a new study.